PubRank

Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

PubWeight™: 2.15‹?› | Rank: Top 2%

🔗 View Article (PMID 26382241)

Published in Lancet on September 14, 2015

Authors

John N Newton1, Adam D M Briggs2, Christopher J L Murray3, Daniel Dicker3, Kyle J Foreman3, Haidong Wang3, Mohsen Naghavi3, Mohammad H Forouzanfar3, Summer Lockett Ohno3, Ryan M Barber3, Theo Vos3, Jeffrey D Stanaway3, Jürgen C Schmidt4, Andrew J Hughes4, Derek F J Fay4, Russell Ecob4, Charis Gresser4, Martin McKee5, Harry Rutter6, Ibrahim Abubakar7, Raghib Ali8, H Ross Anderson9, Amitava Banerjee10, Derrick A Bennett11, Eduardo Bernabé12, Kamaldeep S Bhui13, Stanley M Biryukov3, Rupert R Bourne14, Carol E G Brayne15, Nigel G Bruce16, Traolach S Brugha17, Michael Burch18, Simon Capewell16, Daniel Casey3, Rajiv Chowdhury19, Matthew M Coates3, Cyrus Cooper20, Julia A Critchley21, Paul I Dargan22, Mukesh K Dherani16, Paul Elliott23, Majid Ezzati24, Kevin A Fenton4, Maya S Fraser3, Thomas Fürst25, Felix Greaves26, Mark A Green27, David J Gunnell28, Bernadette M Hannigan29, Roderick J Hay30, Simon I Hay31, Harry Hemingway32, Heidi J Larson33, Katharine J Looker28, Raimundas Lunevicius34, Ronan A Lyons35, Wagner Marcenes36, Amanda J Mason-Jones37, Fiona E Matthews38, Henrik Moller39, Michele E Murdoch40, Charles R Newton2, Neil Pearce6, Frédéric B Piel2, Daniel Pope16, Kazem Rahimi41, Alina Rodriguez42, Peter Scarborough43, Austin E Schumacher3, Ivy Shiue44, Liam Smeeth45, Alison Tedstone4, Jonathan Valabhji46, Hywel C Williams47, Charles D A Wolfe48, Anthony D Woolf49, Adrian C J Davis50

Author Affiliations

1: Public Health England, London, UK; University of Manchester, Manchester, UK. Electronic address: john.newton@phe.gov.uk.
2: University of Oxford, Oxford, UK.
3: Institute for Health Metrics and Evaluation, Seattle, WA, USA.
4: Public Health England, London, UK.
5: Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
6: London School of Hygiene & Tropical Medicine, Oxford Martin School, University of Oxford, Oxford, UK.
7: Public Health England, London, UK; Centre for Infectious Disease Epidemiology and MRC Clinical Trials Unit, London, UK.
8: INDOX Cancer Research Network, Oxford, UK; John Radcliffe Hospital, Oxford, UK; Green-Templeton College, University of Oxford, Oxford, UK.
9: Population Health Research Institute, Hamilton, ON, Canada; MRC-PHE Centre for Environment and Health, London, UK; St George's, University of London, London, UK.
10: University of Birmingham, Birmingham, UK.
11: Clinical Trials Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
12: King's College London Dental Institute, London, UK.
13: Wolfson Institute of Preventive Medicine, Barts & The London School of Medicine, Queen Mary University of London, London, UK.
14: Vision & Eye Research Unit, Anglia Ruskin University, Cambridge, UK.
15: Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK.
16: University of Liverpool, Liverpool, UK.
17: University of Leicester, Leicester, UK.
18: Great Ormond Street Hospital for Children, London, UK.
19: University of Cambridge, Cambridge, UK.
20: MRC Lifecourse Epidemiology Unit, University of Southampton, Southhampton, UK.
21: St George's, University of London, London, UK.
22: Guy's and St Thomas' NHS Foundation Trust, London, UK.
23: Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.
24: MRC-PHE Centre for Population Health, School of Public Health, Imperial College London, London, UK.
25: Department of Infectious Disease Epidemiology, Imperial College London, London, UK.
26: Public Health England, London, UK; Department of Primary Care and Public Health, Imperial College London, London, UK.
27: School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
28: School of Social and Community Medicine, University of Bristol, Bristol, UK.
29: Public Health England, London, UK; Ulster University, Coleraine, Northern Ireland.
30: International Foundation for Dermatology, London, UK.
31: Institute for Health Metrics and Evaluation, Seattle, WA, USA; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
32: University College London, London, UK; Farr Institute of Health Informatics Research, London, UK.
33: Institute for Health Metrics and Evaluation, Seattle, WA, USA; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
34: University of Liverpool, Liverpool, UK; Aintree University Hospital NHS Foundation Trust, University of Liverpool, Liverpool, UK.
35: Farr Institute, College of Medicine, Swansea University, Swansea, UK.
36: Queen Mary University of London.
37: Department of Health Sciences, University of York, York, UK; Adolescent Health Research Unit, University of Cape Town, Cape Town, South Africa.
38: Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK; Institute of Health and Society, Newcastle University, Newcastle, UK.
39: Cancer Epidemiology and Population Health, King's College London, London, UK.
40: West Hertfordshire Hospitals NHS Trust, Hertfordshire, UK.
41: George Institute for Global Health and Division of Cardiovascular Medicine, Oxford Martin School, University of Oxford, Oxford, UK.
42: Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, Imperial College London, London, UK; Mid Sweden University, Sundsvall, Sweden.
43: British Heart Foundation Centre on Population Approaches for NCD Prevention, University of Oxford, Oxford, UK.
44: University of Edinburgh, Edinburgh, Scotland; Northumbria University, Newcastle upon Tyne.
45: Farr Institute of Health Informatics Research, London, UK; London School of Hygiene & Tropical Medicine, Oxford Martin School, University of Oxford, Oxford, UK.
46: NHS England, Leeds, UK; Imperial College Healthcare NHS Trust, London, UK; Imperial College London, London, UK.
47: University of Nottingham, Nottingham, UK.
48: King's College London, London, UK.
49: Royal Cornwall Hospital, Treliske, UK.
50: Public Health England, London, UK; London School of Economics, London, UK; University College London, London, UK.

Articles citing this ↘

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 3.31

Trends in the epidemiology of cardiovascular disease in the UK. Heart (2016) 1.43

Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 1.38

Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 1.31

Low level of attention to health inequalities in prevention planning activities of the Italian Regions. Int J Equity Health (2016) 0.94

Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate. BMC Med (2016) 0.86

The Eatwell Guide: Modelling the Health Implications of Incorporating New Sugar and Fibre Guidelines. PLoS One (2016) 0.83

Measuring Burden of Unhealthy Behaviours Using a Multivariable Predictive Approach: Life Expectancy Lost in Canada Attributable to Smoking, Alcohol, Physical Inactivity, and Diet. PLoS Med (2016) 0.79

Development of a cross-cultural deprivation index in five European countries. J Epidemiol Community Health (2015) 0.78

Identifying Treatment Effect Modifiers in the STarT Back Trial: A Secondary Analysis. J Pain (2016) 0.77

Population health and regional variations of disease burden in Japan, 1990-2015: a systematic subnational analysis for the Global Burden of Disease Study 2015. Lancet (2017) 0.77

Development of a novel walkability index for London, United Kingdom: cross-sectional application to the Whitehall II Study. BMC Public Health (2016) 0.75

Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients. PLoS One (2017) 0.75

A multifaceted implementation strategy versus passive implementation of low back pain guidelines in general practice: a cluster randomised controlled trial. Implement Sci (2016) 0.75

Survival Benefits of Statins for Primary Prevention: A Cohort Study. PLoS One (2016) 0.75

Inequalities in US Life Expectancy by Area Unemployment Level, 1990-2010. Scientifica (Cairo) (2016) 0.75

Will Public Health England lead research? Lancet (2015) 0.75

Significant association between functional microRNA polymorphisms and coronary heart disease susceptibility: a comprehensive meta-analysis involving 16484 subjects. Oncotarget (2016) 0.75

Mortality, greenhouse gas emissions and consumer cost impacts of combined diet and physical activity scenarios: a health impact assessment study. BMJ Open (2017) 0.75

Re-designing the pathway to surgery: better care and added value. Perioper Med (Lond) (2017) 0.75

Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications. J Am Heart Assoc (2016) 0.75

Epidemiology of alcohol dependence in UK primary care: Results from a large observational study using the Clinical Practice Research Datalink. PLoS One (2017) 0.75

Inequalities in healthy life expectancy by Brazilian geographic regions: findings from the National Health Survey, 2013. Int J Equity Health (2016) 0.75

Implementing the Keele stratified care model for patients with low back pain: an observational impact study. BMC Musculoskelet Disord (2017) 0.75

Evidence summary: the relationship between oral health and pulmonary disease. Br Dent J (2017) 0.75

Health impact assessment of the UK soft drinks industry levy: a comparative risk assessment modelling study. Lancet Public Health (2016) 0.75

Protocol: systematic review of the association between socio-economic status and survival in adult head and neck cancer. Syst Rev (2017) 0.75

Two tales of cardiovascular risks-middle-aged women living in Sweden and Scotland: a cross-sectional comparative study. BMJ Open (2017) 0.75

Trends in alcohol-related admissions to hospital by age, sex and socioeconomic deprivation in England, 2002/03 to 2013/14. BMC Public Health (2017) 0.75

Micronutrient deficiencies in the elderly - could ready meals be part of the solution? J Nutr Sci (2017) 0.75

Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet (2017) 0.75

Articles cited by this ↗

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 26.76

Social conditions as fundamental causes of disease. J Health Soc Behav (1995) 23.53

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 14.88

Primary liver cancer: worldwide incidence and trends. Gastroenterology (2004) 11.21

GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64

Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet (2013) 7.77

The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement (2013) 7.69

Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62

Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet (2006) 6.56

Increase in primary liver cancer in the UK, 1979-94. Lancet (1997) 6.15

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11

Dietary intake of antioxidants and risk of Alzheimer disease. JAMA (2002) 4.01

Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ (2010) 3.37

Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet (2014) 3.12

The future of life expectancy and life expectancy inequalities in England and Wales: Bayesian spatiotemporal forecasting. Lancet (2015) 2.79

Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr (2010) 2.67

Salt reduction in the United Kingdom: a successful experiment in public health. J Hum Hypertens (2013) 2.65

What can we conclude from death registration? Improved methods for evaluating completeness. PLoS Med (2010) 2.61

Detection of depression and anxiety in primary care: follow up study. BMJ (2002) 2.44

Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health (2015) 2.32

Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement (2011) 2.26

Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study. PLoS Med (2012) 2.07

Preventing the onset of major depressive disorder: a meta-analytic review of psychological interventions. Int J Epidemiol (2014) 1.85

An integrated approach to cause-of-death analysis: cause-deleted life tables and decompositions of life expectancy. Demogr Res (2008) 1.74

Devolution and divergence in UK health policies. BMJ (2008) 1.72

Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med (2006) 1.52

Systematic review of health behavioral risks and cognitive health in older adults. Int Psychogeriatr (2009) 1.44

Improving the public health utility of global cardiovascular mortality data: the rise of ischemic heart disease. Popul Health Metr (2011) 1.43

Removing the health domain from the Index of Multiple Deprivation 2004-effect on measured inequalities in census measure of health. J Public Health (Oxf) (2006) 1.36

Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study. J Hepatol (2008) 1.29

Can dementia be prevented? Brain aging in a population-based context. Annu Rev Public Health (2004) 1.18

Rates of decline in Alzheimer disease decrease with age. PLoS One (2012) 1.07

Dementia (including Alzheimer's disease) can be prevented: statement supported by international experts. J Alzheimers Dis (2014) 1.06

Reflecting on the global burden of musculoskeletal conditions: lessons learnt from the global burden of disease 2010 study and the next steps forward. Ann Rheum Dis (2014) 1.04

Diagnosis of liver cirrhosis in England, a cohort study, 1998-2009: a comparison with cancer. Am J Gastroenterol (2014) 0.95

[Inequalities in health expectancies in England and Wales--small area analysis from the 2001 Ccensus. Health Stat Q (2007) 0.93

Improving the detection and management of anxiety disorders in primary care. Br J Gen Pract (2011) 0.91

Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs. Prim Care Companion J Clin Psychiatry (2010) 0.89

A neighbourhood level mortality classification of England and Wales, 2006-2009. Health Place (2014) 0.79

Articles by these authors ⇆

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 22.33

Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 11.19

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 9.13

From public to planetary health: a manifesto. Lancet (2014) 3.79

The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol (2013) 2.44

Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet (2016) 1.94

Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet (2015) 1.71

Development assistance for health: past trends, associations, and the future of international financial flows for health. Lancet (2016) 1.67

A cleaner burning biomass-fuelled cookstove intervention to prevent pneumonia in children under 5 years old in rural Malawi (the Cooking and Pneumonia Study): a cluster randomised controlled trial. Lancet (2016) 1.49

Relationships Between Blood Pressure and 24-Hour Urinary Excretion of Sodium and Potassium by Body Mass Index Status in Chinese Adults. J Clin Hypertens (Greenwich) (2015) 1.39

Global and regional trends in COPD mortality, 1990-2010. Eur Respir J (2015) 0.99

A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective. Lancet (2016) 0.87

Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Glob Heart (2014) 0.84

Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Glob Heart (2014) 0.83

Estimation of global and regional incidence and prevalence of abdominal aortic aneurysms 1990 to 2010. Glob Heart (2014) 0.81

Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015. Lancet (2017) 0.80

Life course structural equation model of the effects of prenatal and postnatal growth on adult blood pressure. J Epidemiol Community Health (2014) 0.78

The communities first (ComFi) study: protocol for a prospective controlled quasi-experimental study to evaluate the impact of area-wide regeneration on mental health and social cohesion in deprived communities. BMJ Open (2014) 0.77

Tackling High Blood Pressure in England: A New Approach. J Clin Hypertens (Greenwich) (2015) 0.76

Burden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010. Middle East J Dig Dis (2015) 0.75

Bans of WHO Class I Pesticides in Bangladesh-Suicide Prevention without Hampering Agricultural Output. Int J Epidemiol (2017) 0.75

Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study. Eur J Prev Cardiol (2013) 0.75

The gendered effects of foreign investment and prolonged state ownership on mortality in Hungary: an indirect demographic, retrospective cohort study. Lancet Glob Health (2017) 0.75

Design for the sacubitril/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study). Am Heart J (2017) 0.75

The effect of rapid privatisation on mortality in mono-industrial towns in post-Soviet Russia: a retrospective cohort study. Lancet Public Health (2017) 0.75